Adicet Bio, Inc.(ACET US)
$3.99-0.296.78%Ext:$4.42+0.4310.85%(Market Closed · 00:00:05 UTC)
Get the full experience
We save the real magic for signed-in users.
| Millions USD (ex. Per Share) | FY200806/30/2008 | FY200906/30/2009 | FY201006/30/2010 | FY201106/30/2011 | FY201206/30/2012 | FY201306/30/2013 | FY201406/30/2014 | FY201506/30/2015 | FY201606/30/2016 | FY201706/30/2017 | FY201812/31/2018 | FY201912/31/2019 | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | |||||||||||||||||
| -Cost of Revenue | - | - | 6.4 | 1.3 | |||||||||||||||||
| Gross Profit | - | - | -6.4 | -1.3 | |||||||||||||||||
| -Operating Expenses | 152.0 | 127.6 | 115.7 | 112.5 | |||||||||||||||||
| +Selling, General & Admin | 26.5 | 28.3 | 23.0 | 20.0 | |||||||||||||||||
| +General And Administrative Expenses | 26.5 | 28.3 | 23.0 | 20.0 | |||||||||||||||||
| +Selling And Marketing Expenses | - | - | - | — | |||||||||||||||||
| +Research and Development | 106.0 | 99.3 | 99.1 | 93.8 | |||||||||||||||||
| +Other Operating Expenses | 19.5 | - | -6.4 | -1.3 | |||||||||||||||||
| Operating Income | -152.0 | -127.6 | -122.1 | -113.8 | |||||||||||||||||
| +Non Operating Income | 19.3 | 21.2 | 11.1 | 10.3 | |||||||||||||||||
| +Interest Income, Net | 10.0 | 10.7 | 5.7 | 5.4 | |||||||||||||||||
| +Interest Income | 10.0 | 10.7 | 5.8 | 5.4 | |||||||||||||||||
| -Interest Expense | - | 0.0 | 0.0 | 0.1 | |||||||||||||||||
| +Other Non-Op Income | 9.4 | 10.5 | 5.3 | 5.0 | |||||||||||||||||
| Pretax Income | -142.7 | -117.1 | -116.8 | -108.8 | |||||||||||||||||
| -Income Tax Expense | - | - | - | - | |||||||||||||||||
| Income from Cont Ops | -142.7 | -117.1 | -116.8 | -108.8 | |||||||||||||||||
| -Net Extraordinary Losses | - | - | - | - | |||||||||||||||||
| +Discounted operations | - | - | - | - | |||||||||||||||||
| +XO & Accounting Changes | - | - | - | - | |||||||||||||||||
| Income Incl. MI | -142.7 | -117.1 | -116.8 | -108.8 | |||||||||||||||||
| -Minority Interests | - | - | - | - | |||||||||||||||||
| Net Income, GAAP | -142.7 | -117.1 | -116.8 | -108.8 | |||||||||||||||||
| -Prfrrd Div & Other | - | - | - | - | |||||||||||||||||
| Net Income Avail To Common | -142.7 | -117.1 | -116.8 | -108.8 | |||||||||||||||||
| Weighted Average Shs Out | 2,690,151.0 | 5,491,652.0 | 6,891,336.0 | 29,021,705.0 | |||||||||||||||||
| EPS | -53.0 | -21.3 | -17.0 | -14.9 | |||||||||||||||||
| Weighted Average Shs Out Dil | 2,690,150.0 | 5,491,652.0 | 6,891,336.0 | 29,021,705.0 | |||||||||||||||||
| EPS Diluted | -53.0 | -21.3 | -17.0 | -14.9 | |||||||||||||||||
